multiple myeloma

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen makes EMA marketing application for talquetamab for ...

The Janssen Pharmaceutical Companies of Johnson & Johnson have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA), seeking approval of talqueta

Oncology

After a slow start for expensive CAR-T therapies, drug devel...

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel o

News

ASH: J&J makes case for just-filed GPRC5D drug talquetamab

Johnson & Johnson is in pole position to bring a drug targeting GPRC5D to market as a new therapeutic approach to multiple myeloma, and told delegates at ASH yesterday why its talquetam

News

GSK will pull Blenrep from US market after failed trial

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US

News

GSK's Blenrep hopes take a knock as drug fails trial

GSK has great expectations for its BCMA-directed cancer drug Blenrep, but a failed phase 3 trial in relapsed or refractory multiple myeloma has raised doubts about its prospects – and even

News

J&J nabs FDA okay for BCMA bispecific Tecvayli

Johnson & Johnson has secured another regulatory approval for its BCMAxCD3 bispecific antibody for multiple myeloma – Tecvayli – adding to the wide range of therapies available for the

Janssen makes EMA marketing application for talquetamab for ...

After a slow start for expensive CAR-T therapies, drug devel...

ASH: J&J makes case for just-filed GPRC5D drug talquetamab

GSK will pull Blenrep from US market after failed trial

GSK's Blenrep hopes take a knock as drug fails trial

J&J nabs FDA okay for BCMA bispecific Tecvayli

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

multiple myeloma

Editor's Picks